Axial

Meliora Therapeutics is a biotech startup focused on developing innovative cancer therapies through a machine learning-driven platform. The company aims to identify the true mechanisms of action of oncology medications by utilizing a proprietary prediction atlas that maps drug mechanisms. This approach allows Meliora to streamline the drug development process by reducing the time and costs typically associated with traditional methods. By pinpointing the specific actions of therapeutic molecules, Meliora Therapeutics seeks to enhance the efficacy of cancer treatments and accelerate the delivery of life-saving therapies to patients.

Replay is a genome writing company focused on advancing genomic medicine by reprogramming biology through the writing and delivery of large DNA sequences. The company has developed a hypoimmunogenic induced pluripotent stem cell (iPSC) therapeutic platform, which aims to enhance the effectiveness of gene therapy and genome editing. By leveraging innovative technologies, Replay seeks to redefine the landscape of genetic treatments and improve patient outcomes in various therapeutic areas.

Developer of a deep learning platform intended to deliver medicines of transformational efficacy for patients. the company platform delivers transformational medicines through 3D deep learning and cutting-edge drug discovery technologies, enabling doctors in treating undruggable disease targets.

Adaptyv Bio is focused on developing a protein engineering platform that leverages cell-free synthetic biology and high-throughput nanofluidics. The company’s technology aims to identify new antibodies for various diseases by bridging the gap between computational predictions and experimental validation. This innovative approach enhances the ability of healthcare providers to improve patient outcomes through more effective therapeutic options.

Zeit Medical specializes in the development of innovative technology for diagnosing and treating neurological injuries. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has created a headband that continuously monitors the electrical activity of the brain. This device integrates seamlessly with existing electroencephalogram (EEG) systems and facilitates automated pre-screening and annotation of extensive datasets. By identifying specific patterns in EEG readings, Zeit Medical enables physicians to detect the onset of strokes and provide precise treatment, significantly improving patient outcomes in neurological care.

Operator of a biotechnology platform intended to increase binding affinity and improve consistency to help create personalized, precision cancer vaccines for patients of all backgrounds. The company's platform focuses on developing a single-molecule, massively parallel, de novo next-generation protein sequencing platform, enabling scientists and researchers to develop novel therapeutics and diagnostics and ultimately understand human biology and disease.

Parallel Health is a skin microbiome company from the SF Bay Area, aims to revolutionize skin and body care by providing deep insights and true personalization through best-in-class testing and targeted microbial formulations.